Previous Close | 51.09 |
Open | 51.15 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 50.68 - 51.47 |
52 Week Range | 48.86 - 80.04 |
Volume | |
Avg. Volume | 1,699,990 |
Market Cap | 7.097B |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | 26.44 |
EPS (TTM) | 1.92 |
Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 66.36 |
Subscribe to Yahoo Finance Plus to view Fair Value for GMED
Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for Super Micro Computer, and upgrades for Dell, CVS, Globus Medical , and Rackspace Technology. Dell (NYSE:DELL) shares were rising nearly 2% pre-market Tuesday after Daiwa Securities upgraded the PC maker to Outperform from Neutral and raised its price target to $80.00 from $50.00, as reported in real time on InvestingPro. The analysts noted that Dell's Q2/24 earnings report last month exceeded consensus expectations with strong revenue of $22.9 billion, which beat estimates by $2.1B.
Globus Medical's (GMED) Precice Bone Transport is a less intrusive treatment that reduces complications for both the patient and the surgeon and is designed for various bone abnormalities.